What changed
2026-07-31 21:12 UTC → 2026-08-02 18:06 UTC ·
added
removed
Bryan Johnson’s July 5, 2026 disclosure of After announcing an autoimmune gastritis sparked discussion about diagnosis, iron deficiency and overlap with other autoimmune disorders. He reported early atrophy of acid‑producing cells, pledged a million‑cell immune‑sequencing effort, and emphasized lifelong iron and B12 supplementation. On July 30, 2026 he posted diagnosis on X that July 5 2026, Johnson used his incurable stomach condition had led him X post on July 30 to question whether his intensive Blueprint longevity regimen had been taken too far, writing “Been thinking things over and wonder if I’ve taken this whole longevity thing too far.” The post far. He reiterated details the components of his program—plant‑based diet, exhaustive health biomarker monitoring, daily supplements, and experimental plasma transfusions from his teenage son—while acknowledging possible overreach. Johnson son—and noted the creation of an iPSC line dubbed “Baby Bryan,” which resides only in a petri dish for future organ‑regeneration research. The cost of Project Blueprint has spent reached roughly €8.7 million (about $10 (≈$10 million) on Project Blueprint, a cost that averages overall, about $2 million per year. He also highlighted In early August, Johnson again voiced caution, saying the creation of “Baby Bryan,” a line autoimmune diagnosis prompted him to reassess the safety limits of induced pluripotent stem cells derived from his own blood. Scientists clarified anti‑aging pursuits. He emphasized that the “Baby Bryan” cells are not a human clone but a standard iPSC line kept in a petri dish being used to generate organoids for future organ‑regeneration research. His health setback disease modeling and public self‑reflection have revived drug testing, and experts reminded that producing fully functional transplantable organs remains far from clinical reality. His continued self‑scrutiny has kept the debate alive over the safety, ethics ethical and realistic prospects medical boundaries of extreme bio‑hacking and longevity experiments. research.